Exact Mass: 293.1415714

Oxaprozin

3-(diphenyl-1,3-oxazol-2-yl)propanoic acid

Oxaprozin is only found in individuals that have used or taken this drug. It is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID), used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis.Anti-inflammatory effects of Oxaprozin are believed to be due to inhibition of cylooxygenase in platelets which leads to the blockage of prostaglandin synthesis. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation. Oxaprozin is a non-selective NSAID, with a cell assay system showing lower COX-2 selectivity implying higher COX-1 selectivity. M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors Oxaprozin is an orally active and potent COX inhibitor, with IC50 values of 2.2 μM for human platelet COX-1 and and 36 μM for IL-1-stimulated human synovial cell COX-2, respectively. Oxaprozin also inhibits the activation of NF-κB. Oxaprozin induces cell apoptosis. Oxaprozin shows anti-inflammatory activity. Oxaprozin-mediated inhibition of the Akt/IKK/NF-κB pathway contributes to its anti-inflammatory properties[1][2].

Ondansetron

9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one

Ondansetron is a well tolerated drug with few side effects. Headache, constipation, and dizziness are the most commonly reported side effects associated with its use. There have been no significant drug interactions reported with this drugs use. It is broken down by the hepatic cytochrome P450 system and it has little effect on the metabolism of other drugs broken down by this system; Ondansetron is a serotonin 5-HT3 receptor antagonist used mainly to treat nausea and vomiting following chemotherapy. Its effects are thought to be on both peripheral and central nerves. One part is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata, the other is a blockage of serotonin receptors in the chemoreceptor trigger zone. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors; A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties; Ondansetron (INN) is a serotonin 5-HT3 receptor antagonist used mainly to treat nausea and vomiting following chemotherapy. Its effects are thought to be on both peripheral and central nerves. One part is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata, the other is a blockage of serotonin receptors in the chemoreceptor trigger zone. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors. [HMDB] Ondansetron is a well tolerated drug with few side effects. Headache, constipation, and dizziness are the most commonly reported side effects associated with its use. There have been no significant drug interactions reported with this drugs use. It is broken down by the hepatic cytochrome P450 system and it has little effect on the metabolism of other drugs broken down by this system; Ondansetron is a serotonin 5-HT3 receptor antagonist used mainly to treat nausea and vomiting following chemotherapy. Its effects are thought to be on both peripheral and central nerves. One part is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata, the other is a blockage of serotonin receptors in the chemoreceptor trigger zone. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors; A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties; Ondansetron (INN) is a serotonin 5-HT3 receptor antagonist used mainly to treat nausea and vomiting following chemotherapy. Its effects are thought to be on both peripheral and central nerves. One part is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata, the other is a blockage of serotonin receptors in the chemoreceptor trigger zone. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors. A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants > A04AA - Serotonin (5ht3) antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D003879 - Dermatologic Agents > D000982 - Antipruritics CONFIDENCE standard compound; INTERNAL_ID 2746 CONFIDENCE standard compound; INTERNAL_ID 8525 D002491 - Central Nervous System Agents Ondansetron (GR 38032; SN 307) is a highly selective 5-HT3 receptor antagonist, with IC50 value of 103 pM. Ondansetron exerts antiemetic effects by antagonizing 5-HT receptor located on local neurons in the peripheral and central nervous system. Ondansetron suppresses nausea and vomiting caused by chemotherapy and radiation therapy. Ondansetron has orally bioactivity[1][2][3][4][5][6][7][8].

Anastrozole

alpha,alpha,Alpha,alpha-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile

Anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women. It is used both in adjuvant therapy (i.e. following surgery) and in metastatic breast cancer. It decreases the amount of estrogens that the body makes. Anastrozole belongs in the class of drugs known as aromatase inhibitors. It inhibits the enzyme aromatase, which is responsible for converting androgens (produced by women in the adrenal glands) to estrogens. CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7616; ORIGINAL_PRECURSOR_SCAN_NO 7613 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7651; ORIGINAL_PRECURSOR_SCAN_NO 7649 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7606; ORIGINAL_PRECURSOR_SCAN_NO 7604 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7609; ORIGINAL_PRECURSOR_SCAN_NO 7607 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7592; ORIGINAL_PRECURSOR_SCAN_NO 7590 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7638; ORIGINAL_PRECURSOR_SCAN_NO 7636 L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BG - Aromatase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist CONFIDENCE standard compound; INTERNAL_ID 2750 CONFIDENCE standard compound; INTERNAL_ID 8532 D000970 - Antineoplastic Agents

N-Acetylmuramate

(2R)-2-{[(3R,4R,5S,6R)-2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-4-yl]oxy}propanoic acid

This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group. KEIO_ID A191

Melosatin B

4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine

4-{13-methyl-4,6-dioxa-11,12-diazatricyclo[7.5.0.0³,⁷]tetradeca-1,3(7),8,10,12-pentaen-10-yl}aniline

D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D020011 - Protective Agents

Dehydronuciferine

15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(16),2,4,6,8,13(17),14-heptaene

Dehydronuciferine is found in coffee and coffee products. Dehydronuciferine is an alkaloid from the leaves of Nelumbo nucifera (East Indian lotus). Dehydronuciferine is an isoquinoline alkaloid. Dehydronuciferine is a natural product found in Nelumbo nucifera with data available. Dehydronuciferine is isolated from the leaves of Nelumbo nucifera Gaertn, a acetylcholinesterase (AChE) inhibitor with an IC50 of 25 μg/mL[1]. Dehydronuciferine is isolated from the leaves of Nelumbo nucifera Gaertn, a acetylcholinesterase (AChE) inhibitor with an IC50 of 25 μg/mL[1].

N-Fructosyl isoleucine

(2S)-3-methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl}amino)pentanoic acid

Fructose aminoacids are naturally occurring compounds derived from D-fructose and L-aminoacids. They are amadori products resulting from sugar-aminoacid interactions in food products, especially cooked foods [CCD] N-(1-Deoxy-1-fructosyl)isoleucine is classified as a Natural Food Constituent (code WA) in the DFC.

Phenylalanyllysine

(2S)-6-Amino-2-{[(2S)-2-amino-3-phenylpropanoyl]amino}hexanoic acid

Phenylalanyllysine is a dipeptide composed of phenylalanine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

(3R)-3,4-Dihydroxy-3-(hydroxymethyl)butanenitrile 4-glucoside

3,4-dihydroxy-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)butanenitrile

(3R)-3,4-Dihydroxy-3-(hydroxymethyl)butanenitrile 4-glucoside is found in cereals and cereal products. (3R)-3,4-Dihydroxy-3-(hydroxymethyl)butanenitrile 4-glucoside is a constituent of barley (Hordeum vulgare). Constituent of barley (Hordeum vulgare). (3R)-3,4-Dihydroxy-3-(hydroxymethyl)butanenitrile 4-glucoside is found in barley and cereals and cereal products.

Koenimbine

13-methoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1,3,7,9,11(16),12,14-heptaene

Koenimbine is found in herbs and spices. Koenimbine is an alkaloid from leaves and fruits of Murraya koenigii (curryleaf tree

Lysylphenylalanine

(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanoic acid

Lysylphenylalanine is a dipeptide composed of lysine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Phenylalanylglutamine

(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carbamoylbutanoic acid

Phenylalanylglutamine is a dipeptide composed of phenylalanine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

E-10-Hydroxyamitriptyline

(2E)-2-[3-(dimethylamino)propylidene]tricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-9-ol

E-10-Hydroxyamitriptyline is only found in individuals that have used or taken Amitriptyline. E-10-Hydroxyamitriptyline is a metabolite of Amitriptyline. E-10-hydroxyamitriptyline belongs to the family of Dibenzocycloheptenes. These are compounds containing a dibenzocycloheptene moiety, which consists of two benzene connected by a cycloheptene ring.

Glutaminylphenylalanine

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-3-phenylpropanoic acid

Glutaminylphenylalanine is a dipeptide composed of glutamine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Phenylalanyl-Gamma-glutamate

2-Amino-4-[(2-amino-3-phenylpropanoyl)-C-hydroxycarbonimidoyl]butanoate

Phenylalanyl-Gamma-glutamate is a dipeptide composed of phenylalanine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Galactosyl 4-hydroxyproline

(2S,3R,4S,5R,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl (2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid

Galactosyl 4-hydroxyproline is found in cereals and cereal products. Galactosyl 4-hydroxyproline is isolated from hydrolyzed wheat endosperm. Isolated from hydrolysed wheat endosperm. Galactosyl 4-hydroxyproline is found in cereals and cereal products.

4-Hydroxyproline galactoside

(2S,4R)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyrrolidine-2-carboxylic acid

4-Hydroxyproline galactoside is found in cereals and cereal products. 4-Hydroxyproline galactoside is isolated from hydrolyzed wheat endosperm. Isolated from hydrolysed wheat endosperm. 4-Hydroxyproline galactoside is found in cereals and cereal products.

N-(1-Deoxy-1-fructosyl)leucine

(2S)-4-methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl}amino)pentanoic acid

Fructose aminoacids are naturally occurring compounds derived from D-fructose and L-aminoacids. They are amadori products resulting from sugar-aminoacid interactions in food products, especially cooked foods [CCD] N-(1-Deoxy-1-fructosyl)leucine is classified as a Natural Food Constituent (code WA) in the DFC.

N-Acetyl-3-hydroxyprocainamide

N-[2-(diethylamino)ethyl]-3-hydroxy-4-[(1-hydroxyethylidene)amino]benzene-1-carboximidic acid

N-Acetyl-3-hydroxyprocainamide is a metabolite of procainamide. Procainamide is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias, classified by the Vaughan Williams classification system as class Ia. (Wikipedia)

Quifenadine

{1-azabicyclo[2.2.2]octan-2-yl}diphenylmethanol

Quifenadine is a second-generation H1-antihistamine.

Pimethixene

1-methyl-4-(9H-thioxanthen-9-ylidene)piperidine

C19H19NS (293.1238134)

R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Pimethixene is a thioxanthene H1-antihistamine.

3,4,5-Trihydroxypentanoylcarnitine

3-[(3,4,5-trihydroxypentanoyl)oxy]-4-(trimethylazaniumyl)butanoate

3,4,5-trihydroxypentanoylcarnitine is an acylcarnitine. More specifically, it is an 3,4,5-trihydroxypentanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3,4,5-trihydroxypentanoylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 3,4,5-trihydroxypentanoylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

(Z)-10-Hydroxyamitriptyline

2-[3-(dimethylamino)propylidene]tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-9-ol

[1,1'-Biphenyl]-4-carbonitrile, 4'-(heptyloxy)-

[1,1-Biphenyl]-4-carbonitrile, 4-(heptyloxy)-

7-Acetamidonitrazepam

N-(2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-7-yl)acetamide

Amitriptylinoxide

N,N-dimethyl-3-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene}propanamine oxide

C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

Acridine carboxamide

N-[2-(Dimethylamino)ethyl]acridine-4-carboximidate

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors

Paclobutrazol

1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pentan-3-ol

3-Methoxy-N-p-tolylquinoxalin-2-carboxamide

3-Methoxy-N-(4-methylphenyl)quinoxaline-2-carboximidate

Lysyl-Phenylalanine

2-[(2,6-diamino-1-hydroxyhexylidene)amino]-3-phenylpropanoic acid

stephenanthrine

Phenanthro(3,4-d)-1,3-dioxole-5-ethanamine, N,N-dimethyl-

11-Hydroxy-6-methyl-5,3a-(iminopropano)spiro[tetrahydrofuran-2,3-hydrindane]-2,4-dione

clausamine A

Salviadione

N-Formylannonaine

CHEMBL1194303

8-Hydroxydehydroroemerine

Veiutamine

Chlorantene B

Dehydronuciferine

15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(16),2,4,6,8,13(17),14-heptaene

Dehydronuciferine is isolated from the leaves of Nelumbo nucifera Gaertn, a acetylcholinesterase (AChE) inhibitor with an IC50 of 25 μg/mL[1]. Dehydronuciferine is isolated from the leaves of Nelumbo nucifera Gaertn, a acetylcholinesterase (AChE) inhibitor with an IC50 of 25 μg/mL[1].

2-(3,4-Dimethoxyphenylethyl)quinoline

Des-N-methylnoracronycine

FK 1052

2-Imino-1-isobutyl-5-oxo-1,5-dihydro-2H-dipyrido[1,2-a:2,3-d]pyrimidine-3-carbonitrile

C16H15N5O (293.127654)

Atanisatine

1-(4-Methoxybenzyl)-6,7-methylenedioxyisoquinoline

substance FKI-1938A

lannotinidine E

6-hydroxy-3,3-dimethyl-12H-pyrano[2,3-c]acridin-7-one

dehydroxylopine

C16H23NO4

Indizoline

8-methoxy-3,3,9-trimethyl-3,11-dihydro-pyrano[3,2-a]carbazole|Koenimbin

pyrayafoline|Pyrayafoline A|Pyrayafoline-A

C18H15NO3

Clauszoline H

ZINC00057191

Clauraila D

A natural product found in Clausena harmandiana.

Ethyl 2-(4-ethoxy-4-oxobutanamido)benzoate

3-Hydroxy-2-oxodendrobine

Clauszoline G

2-acetamido-4-O-((S)-1-carboxyethyl)-2-deoxy-D-glucopyranose|2-acetamido-4-O-<(S)-1-carboxyethyl>-2-deoxy-D-glucopyranose

5-methoxy-3,3,8-trimethyl-3,11-dihydro-pyrano[3,2-a]carbazole|Heptazolidine

2-(3,4-Dimethoxyphenethyl)quinoline

Caldensine

N-Hormyldehydrocaaverine

AKOS034145070

(2E,7E,9E)-N-(2-hydroxy-2-methylpropyl)-6,11-dioxo-2,7,9-dodecatrienamide

Harmandianamine A

Lysicamine

Ac-2-(4-Hydroxyphenyl)-1-methyl-4(1H)-quinolinone

juncuenin E

Clauraila E

COC1=C(C=2NC3=CC=CC=C3C=2C=C1C=O)C=CC(C)C

N,N-di(methoxycarbonylethyl)-2,6-dimethylaniline

3-(4-formylanilino)-4,7-dihydroxyoct-5-enoic acid

Tambjamine F

6,6a-dihydrodemethoxyguadiscine

Mupamine

Heptaphylline

(1S,2S,5R,7R,9S,E)-5-(5-hydroxy-9-methyl-3-oxo-4-oxatricyclo^{[3.3.1.02,7]^{non-2-yl)-2-methyl-4-oxopent-2-enamide|Brasilamide A}}

5-acetyl-3-deoxyadenosine|5-O-acetyl-3-deoxyadenosine|9-(5-O-acetyl-3-deoxy-beta-D-erythro-pentofuranosyl)adenine

(8aR,9R,11R,12aR)-3-chloro-6,7,8,8a,9,10,11,12-octahydro-14-hydroxy-11-methyl-4H-9,1-ethanylylidenebenzo[i]quinolizin-13-one|2-chlorohuperzine E

7-Methoxyglycomaurin

Clauszoline B

N-[2-(1H-indol-3-yl)ethyl]-2-(methylamino)benzamide

Annoretine

6,6a-dehydronorlaureline

4-{(2E)-2-[dihydro-5-methyl-2-oxo-5-(2-oxopropyl)furan-3(2H)-ylidene]ethyl}piperidine-2,6-dione|dipteronine A

ekeberginine

O-Methylmurrayamine A

Thr Ser Ser

SCHEMBL7588968

Ser Ser Thr

Ser Thr Ser

Gly-Phe-Ala

L-Phenylalanine, N-(N-glycyl-L-alanyl)-

BETA-GAL-NONOATE

Phe Ala Gly

a jasmonoyl-1-aminocyclopropane-1 carboxylate

Paclobutrazol

Pesticide6_Paclobutrazol_C30H40Cl2N6O2_1H-1,2,4-Triazole-1-ethanol, beta-[(4-chlorophenyl)methyl]-alpha-(1,1-dimethylethyl)-

CONFIDENCE standard compound; EAWAG_UCHEM_ID 3705

oxaprozin

M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors Oxaprozin is an orally active and potent COX inhibitor, with IC50 values of 2.2 μM for human platelet COX-1 and and 36 μM for IL-1-stimulated human synovial cell COX-2, respectively. Oxaprozin also inhibits the activation of NF-κB. Oxaprozin induces cell apoptosis. Oxaprozin shows anti-inflammatory activity. Oxaprozin-mediated inhibition of the Akt/IKK/NF-κB pathway contributes to its anti-inflammatory properties[1][2].

Anastrozole

L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BG - Aromatase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents

STEPHENANTHRINE

NCGC00160247-01!STEPHENANTHRINE

C14H19N3O4_N~5~-Carbamoyl-N~2~-(phenylacetyl)ornithine

NCGC00385854-01_C14H19N3O4_N~5~-Carbamoyl-N~2~-(phenylacetyl)ornithine

ondansetron

Ondansetron aka "9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one"

A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants > A04AA - Serotonin (5ht3) antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D003879 - Dermatologic Agents > D000982 - Antipruritics D002491 - Central Nervous System Agents Ondansetron (GR 38032; SN 307) is a highly selective 5-HT3 receptor antagonist, with IC50 value of 103 pM. Ondansetron exerts antiemetic effects by antagonizing 5-HT receptor located on local neurons in the peripheral and central nervous system. Ondansetron suppresses nausea and vomiting caused by chemotherapy and radiation therapy. Ondansetron has orally bioactivity[1][2][3][4][5][6][7][8].

n-acetylmuramic acid

(R)-2-Acetamido-3-O-(1-carboxyethyl)-2-deoxy-D-glucose

3,4,5,6-tetradehydrogeissoschizol

[C19H21N2O]+ (293.1653796)

N-Fructosyl isoleucine

Annotation level-3

O-DeMethylfoliosidine

SubCategory_DNP: : Alkaloids derived from anthranilic acid, Quinoline alkaloids, Foliosidine alkaloids

Fabesetron

C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3660; ORIGINAL_PRECURSOR_SCAN_NO 3659 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3638; ORIGINAL_PRECURSOR_SCAN_NO 3636 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3651; ORIGINAL_PRECURSOR_SCAN_NO 3649 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3679; ORIGINAL_PRECURSOR_SCAN_NO 3675 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3688; ORIGINAL_PRECURSOR_SCAN_NO 3687 DATASET 20200303_ENTACT_RP_MIX505; CONFIDENCE standard compound; INTERNAL_ID 393; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3974; ORIGINAL_PRECURSOR_SCAN_NO 3970 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3974; ORIGINAL_PRECURSOR_SCAN_NO 3970 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8035; ORIGINAL_PRECURSOR_SCAN_NO 8033 INTERNAL_ID 393; CONFIDENCE standard compound; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8035; ORIGINAL_PRECURSOR_SCAN_NO 8033 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8049; ORIGINAL_PRECURSOR_SCAN_NO 8045 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8030; ORIGINAL_PRECURSOR_SCAN_NO 8029 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8041; ORIGINAL_PRECURSOR_SCAN_NO 8036 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8063; ORIGINAL_PRECURSOR_SCAN_NO 8062 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7948; ORIGINAL_PRECURSOR_SCAN_NO 7944

Naphthol AS-OL

3-Hydroxy-N-(2-methoxyphenyl)-2-naphthamide

CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5054; ORIGINAL_PRECURSOR_SCAN_NO 5049 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5079; ORIGINAL_PRECURSOR_SCAN_NO 5074 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5032; ORIGINAL_PRECURSOR_SCAN_NO 5030 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5075; ORIGINAL_PRECURSOR_SCAN_NO 5073 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5061; ORIGINAL_PRECURSOR_SCAN_NO 5057 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5055; ORIGINAL_PRECURSOR_SCAN_NO 5054 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9521; ORIGINAL_PRECURSOR_SCAN_NO 9519 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9583; ORIGINAL_PRECURSOR_SCAN_NO 9581 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9626; ORIGINAL_PRECURSOR_SCAN_NO 9624 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9630; ORIGINAL_PRECURSOR_SCAN_NO 9625 CONFIDENCE standard compound; INTERNAL_ID 649; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9646; ORIGINAL_PRECURSOR_SCAN_NO 9645

7-Acetamidonitrazepam

Gly Phe Ala

C14H16FN3O3 (293.11756379999997)

Desethylenenorfloxacin

1,2,3,4-Tetrahydro-2-[(isopropylamino)methyl]-7-nitro-6-quinolinecarboxylic acid

Phe Gly Ala

Ala Gly Phe

Gly Ala Phe

Ala Phe Gly

Phe Gln

Lys Phe

Gln Phe

Phe Lys

Pimethixene

C19H19NS (293.1238134)

R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

β-Gal-NONOate

1-O-(1-pyrrolidinyl-ONN-azoxy)-β-D-glucopyranose

CAY10398

4-(dimethylamino)-N-[6-(hydroxyamino)-6-oxohexyl]-benzamide

GLN-Phe

2-(2-amino-3-phenylpropanamido)-4-carbamoylbutanoic acid

Lys-phe

6-amino-2-(2-amino-3-phenylpropanamido)hexanoic acid

A dipeptide formed from L-lysine and L-phenylalanine residues.

Phe-GLN

2-(2-amino-4-carbamoylbutanamido)-3-phenylpropanoic acid

Phe-lys

2-(2,6-diaminohexanamido)-3-phenylpropanoic acid

Phe-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]-3-phenylpropanoic acid

GGlu-Phe

2-(2-amino-3-phenylpropanamido)-4-(C-hydroxycarbonimidoyl)butanoic acid

Galactosyl 4-hydroxyproline

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 4-hydroxypyrrolidine-2-carboxylate

4-Hydroxyproline galactoside

4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyrrolidine-2-carboxylic acid

Koenimbin

13-methoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1,3,7,9,11,13,15-heptaene

(3R)-3,4-Dihydroxy-3-(hydroxymethyl)butanenitrile 4-glucoside

3,4-dihydroxy-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)butanenitrile

N,N-(acridine-3,6-diyl)diacetamide

Alcyopterosin J

C14H15D3N4O3 (293.15671533399995)

9H-Carbazole-3-boronic acid pinacol ester

C18H20BNO2 (293.158701)

Trimethoprim-d3

METHYL 1-(4-(2-OXOACETYL)PHENYL)PIPERIDINE-4-CARBOXYLATE HYDRATE

2-(2-AMINOPHENYL)-5-(4-(TERT-BUTYL)PHENYL)-1,3,4-OXADIAZOLE

(3S,4S)-TERT-BUTYL 3-HYDROXY-4-(4-HYDROXYPHENYL)PIPERIDINE-1-CARBOXYLATE

3-(2-CARBOXY-ETHYL)-MORPHOLINE-4-CARBOXYLIC ACID BENZYL ESTER

2-(1,3-benzoxazol-2-yl)-1-(4-tert-butylphenyl)ethanone

N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine hydrochloride

3,5-Dip-tolyl-4,5-dihydro-1H-pyrazole-1-carboxamide

Benzoic acid, 4-[(3-formyl-1H-indol-1-yl)methyl]-, methyl ester (9CI)

Benzoic acid, 4-[(3-formyl-2-methyl-1H-indol-1-yl)methyl]- (9CI)

(S)-(3B,12B)-12,20-DIHYDROXYDAMMAR-24-EN-3-YLBETA-D-GLUCOPYRANOSIDE

1-(3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-YL)ETHAN-1-ONE

2-(4-ETHOXY-PHENYL)-QUINOLINE-4-CARBOXYLIC ACID

2-(2-Ethoxyphenyl)quinoline-4-carboxylic acid

2-(3-BENZYLOXY-4-METHOXY-PHENYL)-ETHYLAMINE HCL

TRANS-4-(BOC-AMINO)CYCLOHEXYL METHANESULFONATE

C12H23NO5S (293.1296868)

CHEMBRDG-BB 4011737

(1-Furan-2-yl-2-phenyl-ethyl)-(4-methoxy-phenyl)-amine

2-[(Tert-Butyloxycarbonyl)]-6-Hydroxy-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid

3-o-acetyl-2-deoxyadenosine

(2S,5R)-5-Hydroxy-1,2-piperidinedicarboxylic acid 2-methyl 1-benzyl ester

2-(3-Methoxyphenyl)-6-methylquinoline-4-carboxylic acid

2-(2-Methoxyphenyl)-8-methylquinoline-4-carboxylic acid

2-(3-Methoxyphenyl)-8-methylquinoline-4-carboxylic acid

2-(4-Methoxyphenyl)-8-methylquinoline-4-carboxylic acid

tri-n-butyltin deuteride

C12H27DSn (293.127564978)

1-(4-nitrophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole

C15H23N3OS (293.15617480000003)

Ethyl [3-(triethoxysilyl)propyl]carbamate

C12H27NO5Si (293.1658412)

dimazole

Diamthazole

D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use C254 - Anti-Infective Agent > C514 - Antifungal Agent

(S)-2-((tert-Butoxycarbonyl)amino)-5-phenylpentanoic acid

boc-d-2-amino-5-phenyl-pentanoic acid dcha salt

C15H16FNO4 (293.10633079999997)

2-METHOXY-4-(4-METHYLPIPERAZIN-1-YL)ANILINE DIHYDROCHLORIDE

C12H21Cl2N3O (293.1061596)

ethyl 4-(4-fluorophenyl)-1-methyl-2,6-dioxopiperidine-3-carboxylate

2-N-BOC-2-AMINOMETHYL-3-M-TOLYL-PROPIONIC ACID

2-N-BOC-2-AMINOMETHYL-3-P-TOLYL-PROPIONIC ACID

N-(2-OXO-5-PHENYL-2,3-DIHYDRO-1H-BENZO[E][1,4]DIAZEPIN-3-YL)-ACETAMIDE

3-Carboxy-5-nitrobenzeneboronic acid pinacol ester

C13H16BNO6 (293.1070626)

azane,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,furan-2,5-dione,oxirane

2-amino-6-(4-phenylmethoxyphenyl)-1H-pyrimidin-4-one

2-indol-3-yl-4-oxo-4-phenylbutanoic acid

(R)-4-((TERT-BUTOXYCARBONYL)AMINO)-5-PHENYLPENTANOIC ACID

(S)-METHYL3-(4-HYDROXY-3-NITROPHENYL)-2-(2,2,2-TRIFLUOROACETYLAMINO)PROPIONATE

4-Cyanophenyl 4-(3-Butenyloxy)benzoate

Benzaldehyde,4-[bis[2-(acetyloxy)ethyl]amino]-

Spiro[2H-1-benzopyran-2,2-[2H]indol]-6-ol,1,3-dihydro-1,3,3-trimethyl-

N-(3-oxo-1-phenyl-2H-pyrazol-4-yl)-2-phenyl-acetamide

(2-((tert-Butyldimethylsilyloxy)methyl)furo[3,2-b]pyridin-6-yl)methanol

C15H23NO3Si (293.1447128)

Boc-L-2,4-dimethylphe

Boc-D-2,4-dimethylphe

methyl (E)-3-[2-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]prop-2-enoate

tert-butyl-dimethyl-(1-methylsulfonylpiperidin-4-yl)oxysilane

C12H27NO3SSi (293.1480832)

5-Acetyl-8-(benzyloxy)-2(1H)-quinolinone

Boc-(R)-3-Amino-4-(4-methylphenyl)-butyric acid

1-cbz-4(r)-hydroxypyrrolidine-2-carboxylic acid ethyl ester

N-(2-(2-Methoxyphenoxy)ethyl)benzylamine hydrochloride

Dansyl Ethylenediamine

C14H19N3O2S (293.1197914)

5-AMINO-DI-T-BUTYL ISOPHTHALATE

Phosphonic acid,[(diethylamino)carbonyl]-, dibutyl ester (9CI)

C13H28NO4P (293.1755858)

4-FLUORO-2-METHOXYPHENYLBORONICACID

1-(BETA-D-2-DEOXYRIBOFURANOSYL)-4-(1,2,4-TRIAZOL-1-YL)-5-METHYLPYRIMIDIN-2-ONE

DIETHYL 2-(((2-METHOXYPHENYL)AMINO)METHYLENE)MALONATE

Delmetacin

4-(2-QUINOXALINYLAMINO)BENZOIC ACID ETHYL ESTER

1-(2,4-dinitrophenyl)-4-propyl-piperidine

Streptimidone

4-[(PYRIDIN-3-YLMETHYL)-AMINO]-BENZOIC ACID

4-(tert-butoxycarbonyl)-2,3,4,5-tetrahydro-1,4-benzoxazepine-7-carboxylic acid

Boc-L-7-Hydroxy-Tic

2,4-DiMorpholinonitrobenzene

(2R,5R)-5-Hydroxy-1,2-piperidinedicarboxylic acid 2-methyl 1-benzyl ester

(2R-trans)-5-Hydroxy-1,2-piperidinedicarboxylic acid 2-methyl 1-benzyl ester

(2S,5S)-5-Hydroxy-1,2-piperidinedicarboxylic acid 2-methyl 1-benzyl ester

(4-{[(2-Methyl-2-propanyl)oxy]carbonyl}-2,3,4,5-tetrahydro-1,4-be nzoxazepin-7-yl)boronic acid

3-(4-FLUORO-PHENYLCARBAMOYL)-1,2,2-TRIMETHYL-CYCLOPENTANECARBOXYLIC ACID

C16H20FNO3 (293.1427142)

2-(2-methacryloxy-5-methylphenyl)benzotriazole

2-Boc-6-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-1-carboxylic acid

9H-Carbazole-2-boronic acid pinacol ester

C18H20BNO2 (293.158701)

Boc-(R)-3-amino-4-(2-methylphenyl)-butyric acid

Boc-(S)-3-Amino-4-(3-methyl-phenyl)-butyric acid

Boc-(S)-3-Amino-4-(4-methyl-phenyl)-butyric acid

Boc-(S)-3-Amino-5-phenylpentanoic acid

5-Acetyl-8-(phenylmethoxy)-2-quinoline N-Oxide

BENZYL ((S)-1-HYDROXY-3-((R)-TETRAHYDRO-2H-PYRAN-3-YL)PROPAN-2-YL)CARBAMATE

2,4,6-collidinium p-toluenesulfonate

C15H19NO3S (293.1085584)

BETA-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-BENZENEBUTANOIC ACID METHYL ESTER

H-Gly-Phe-Ala-OH

H-Gly-Ala-Phe-OH

CIS-STILBENEBORONIC ACID DIETHANOLAMINE ESTER

C18H20BNO2 (293.158701)

4-Nitrophenyl decanoate

TERT-BUTYL 5-PHENYL-1H-INDOLE-1-CARBOXYLATE

C11H23N3O6 (293.15867779999996)

L-Lysine L-glutamate

Methoxypolyethylene glycol 5,000 acetic acid N-succinimidyl ester

1-BENZYL-2,3-DIMETHYL-1H-INDOLE-5-CARBOHYDRAZIDE

4-Quinolinecarboxylic acid, 2-(4-Methoxyphenyl)-, Methyl ester

Methyl 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate

2-Benzylidene isobutyryl acetanilide

PIPERIDINE-1,4-DIYLBIS(PHENYLMETHANONE)

1H-Indole-1-acetamide,3-formyl-2-methyl-N-2-pyridinyl-(9CI)

1-N-CBZ-PIPERIDIN-4-YLOXY)ACETIC ACID

Benzyl 4-(acetylsulfanyl)-1-piperidinecarboxylate

C15H19NO3S (293.1085584)

promolate

C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

2-PYRIDIN-2-YLMALONIC ACID DI-TERT-BUTYL ESTER

TRANS-1-BENZYL 2-ETHYL 4-HYDROXYPYRROLIDINE-1,2-DICARBOXYLATE

1H-INDOL-3-YL[3-(4-METHOXYPHENYL)OXIRAN-2-YL]METHANONE

tert-butyl N-(1,3-benzodioxol-5-ylmethyl)-N-(2-oxoethyl)carbamate

2-Cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-methanol

C19H16FNO (293.1215858)

Naphthol AS-D

C15H16FNO4 (293.10633079999997)

trans-3-Ethoxycarbonyl-4-(4-flurophenyl)-N-methyl piperdine-2,6-dione

1-[2-(3,5-dimethylphenoxy)ethyl]indole-3-carbaldehyde

CP-94,253

6-(4-ISOPROPOXY-BENZOYLAMINO)-HEXANOIC ACID

Methyl 1-Cbz-5-Hydroxypiperidine-3-carboxylate

7-AMINO-4-(2,5,8-TRIOXANONYL)COUMARIN

α,α-Bis[2-(diMethylaMino)ethyl]-

C16H24ClN3 (293.1658654)

2-amino-3-nitro-4-phenyl-5,6,7,8-tetrahydronaphthalene-1-carbonitrile

5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone

4-Cyanophenyl 4-pentylbenzoate

(3R)-2-(tert-Butoxycarbonyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

Boc-(R)-3-Amino-5-phenylpentanoic acid

2-[(3-METHOXYPHENYLAMINO)-METHYLENE]MALONIC ACID DIETHYL ESTER

3-Hydroxy-4-methoxy-2-naphthanilide

METHYL 4-BENZYL-2-PHENYLOXAZOLE-5-CARBOXYLATE

ABT-724

2-[(4-pyridin-2-ylpiperazin-1-yl)methyl]-1H-benzimidazole

di-n-butyl 4-aminophthalate

1-[1-[(4-Chlorophenyl)Methyl]-4-piperidinyl] piperazine

C16H24ClN3 (293.1658654)

(S)-3-BENZYL 4-METHYL 2,2-DIMETHYLOXAZOLIDINE-3,4-DICARBOXYLATE

Methyl (3R)-(-)-3-(methyl-1H-Indol-3-yl)-3-phenylpropanoate

Methyl 7-isobutyl-1,3-diMethyl-2,4-dioxo-2,3,4,7-tetrahydro-1H-pyrrolo[2,3-d]pyriMidine-6-carboxylate

TERT-BUTYL 3-(((METHYLSULFONYL)OXY)METHYL)PIPERIDINE-1-CARBOXYLATE

C12H23NO5S (293.1296868)

tert-Butyl 4-(((methylsulfonyl)oxy)methyl)piperidine-1-carboxylate

C12H23NO5S (293.1296868)

2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one

methyl5,5-dimethoxy-7,9-dimethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carboxylate

debacarb

METHYL 4-[N-BENZYL-N-(2-ETHOXY-2-OXOETHYL)AMINO]BUTANOATE

Boc-(S)-3-Amino-4-(2-methyl-phenyl)-butyric acid

1-((5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIOPHEN-2-YL)METHYL)PYRROLIDINE

C15H24BNO2S (293.1620714)

(R)-ETHYL1-METHYLPIPERIDINE-3-CARBOXYLATE

(R)-tert-Butyl 2-(dimethylcarbamoyl)piperazine-1-carboxylate hydrochloride

C12H24ClN3O3 (293.1506104)

BENZENEPROPANOIC ACID,-[2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]ETHYL]-

(2S)-2-acetamido-4-methyl-N-(4-nitrophenyl)pentanamide

Boc-(R)-3-Amino-4-(3-methyl-phenyl)-butyric acid

Benzeneethanamine,3-methoxy-4-(phenylmethoxy)-, hydrochloride (1:1)

9,10-Anthracenedione,1-(4-morpholinyl)-

INDOLE-3-(4-OXO)BUTYRICACID

Ethyl N-Cbz-morpholine-2-carboxylate

Methyl 2-methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate

3-NITRO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOIC ACID

C13H16BNO6 (293.1070626)

2-(4-Ethoxy-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

(1-(TERT-BUTYLDIMETHYLSILYL)-5-FLUORO-1H-INDOL-4-YL)BORONIC ACID

C14H21BFNO2Si (293.1418568)

(3R,4S)-1-[(4-Amino-5H-pyrrolo[3,2-D]pyrimidin-7-YL)methyl]-4-[(methylsulfanyl)methyl]pyrrolidin-3-OL

C13H19N5OS (293.1310244)

3-(4-Fluorophenyl)-2-(6-methylpyridin-2-YL)-5,6-dihydro-4H-pyrrolo[1,2-B]pyrazole

2-Quinolineethanol, 4-(dimethylamino)-1,2,3,4-tetrahydro-beta,beta-dimethyl-6-nitro-

Selgantolimod

C14H20FN5O (293.1651802)

Bonzi

Paclobutrazol

N-ACETYL-beta-MURAMIC ACID

Jasmonic acid/1-amino-1-cyclopropane carboxylic acid

H-Ala-Phe-Gly-OH

(R)-6-Allyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

N-(4-ethylphenyl)-4-oxo-3H-phthalazine-1-carboxamide

3-[(6-Methyl-4-phenyl-2-quinazolinyl)amino]-1-propanol

(4-Benzoyl-1-methyl-3-pyrrolidinyl)-phenylmethanone

7-Methyl-4-oxo-2-[(phenylmethyl)amino]-3-pyrido[1,2-a]pyrimidinecarboxaldehyde

1-[(4-Methylphenyl)methyl]-4-(1-pyrrolidinyl)pyrazolo[3,4-d]pyrimidine

3,6-Diacetyl-9-propyl-9H-carbazole

3,6-Diacetyl-9-isopropylcarbazole

3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione

4-(4-Fluorophenyl)-1-cycloropropylmethyl-5-(4-pyridyl)-imidazole

2,6-Diamino-8-(2-dimethylaminoethylsulfanylmethyl)-3H-quinazolin-4-one

C13H19N5OS (293.1310244)

4-[5-(7-Aza-bicyclo[2.2.1]hept-2-yl)-2-fluoro-pyridin-3-yl]-benzonitrile

N,N-Dimethyl-N-(acetyl)-N-(7-nitrobenz-2-oxa-1,3-diazol-4-YL)ethylenediamine

3-Methyl-2-[[2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methylamino]pentanoic acid

N-acetyl-alpha-muramic acid

2-ACETAMIDO-2-DEOXY-3-O-[D-1-CARBOXYETHYL]-D-GLUCOPYRANOSE

salinosporamide E

5,10-Dihydro-9-dimethylallylphenazine 1-carboxylate

C18H17N2O2- (293.1289962)

A monocarboxylic acid anion that is the conjugate base of 5,10-9-dimethylallyldihydrophenazine-1-carboxylic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

Demethyldehydrophos

C10H20N3O5P (293.114052)

JA-Acc

4-Coumaroyl-3-hydroxyagmatine

C14H21N4O3+ (293.1613576)

1-(Gly-Leu-Amino)vinylphosphonic acid

C10H20N3O5P (293.114052)

3,4,5-Trihydroxypentanoylcarnitine

(S)-simeconazole

C14H20FN3OSi (293.1359602)

(R)-simeconazole

C14H20FN3OSi (293.1359602)

4-(2-Furanyl)-3-methyl-5-(4-methylphenyl)-2,4-dihydropyrrolo[3,4-c]pyrazol-6-one

N-(4-hydroxyphenyl)-3-methoxy-2-naphthalenecarboxamide

N-(4-cyclohexylphenyl)-2-(2-hydroxyethylthio)acetamide

C16H23NO2S (293.1449418)

2-[4-(tert-butyl)phenoxy]-N-{[(dimethylamino)carbonyl]oxy}ethanimidamide

3-(1-Benzylpiperidin-4-yl)triazolo[4,5-b]pyridine

5-(Carbamoylamino)-2-[(2-phenylacetyl)amino]pentanoic acid

N-[(E)-(4-Fluorophenyl)methylideneamino]-2,6-dimethylquinolin-4-amine

Phe-Ala-Gly

A tripeptide composed of L-phenylalanine, L-alanine, and glycine joined by peptide linkages.

Ala-Gly-Phe

3-cyclohexyl-N-(1,3-dimethyl-2,6-dioxo-4-pyrimidinyl)propanamide

3-[(2-Hydroxyphenyl)hydrazinylidene]-1-prop-2-enyl-2-indolone

C15H23N3OS (293.15617480000003)

1-(4-Butylphenyl)-3-(4-morpholinyl)thiourea

4-methyl-N-[(1-oxopentylhydrazo)-sulfanylidenemethyl]benzamide

C14H19N3O2S (293.1197914)

2-[1-(4-Methoxyphenyl)iminoethyl]indene-1,3-dione

5-(4-methylphenyl)-N-(3-pyridinylmethyl)-3-isoxazolecarboxamide

2-(2,3-dihydro-1H-inden-5-yloxy)-1-(2,3-dihydroindol-1-yl)ethanone

4-methylbenzoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester

3-[1-(3-Methoxypropyl)-5-thiophen-2-yl-2-pyrrolyl]propanoic acid

C15H19NO3S (293.1085584)

4-(6-Quinolinyl)-1,3,4,6,7,8-hexahydroquinazoline-2,5-dione

3-(1H-indazol-6-yl)-1-propan-2-yl-4-pyrazolo[3,4-d]pyrimidinamine

C15H15N7 (293.138887)

Fructosyl leucine

Sieboldine A(rel)

A natural product found in Lycopodium sieboldii.

Fructosyl isoleucine

4-[[(2,3-Dihydro-2,2-dimethyl-7-benzofuranyloxy)carbonyl]-amino]butanoic acid

9-Ethyl-6-[2-(3-pyridinyl)ethylamino]-2-purinecarbonitrile

C15H15N7 (293.138887)

2-[[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)-4-oxanyl]oxy]propanoic acid

Epoxyqueuine

Ser-Thr-Ser

Thr-Ser-Ser

C13H19N5O3 (293.14878239999996)

N(alpha)-acetyl-L-histidyl-D-prolinamide

2-[(1S,3S,4aS,9aR)-6-amino-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

methyl 2-[(1S,3S,4aR,9aS)-6-amino-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetate

methyl 2-[(1R,3S,4aR,9aS)-6-amino-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetate

2-[(1S,3R,4aS,9aR)-6-amino-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

N-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

2-[(1R,3S,4aS,9aR)-6-amino-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

2-[(1S,3R,4aR,9aS)-6-amino-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

2-[(1R,3R,4aS,9aR)-6-amino-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

2-[(3E)-3-ethylidene-1,2,4,12-tetrahydroindolo[2,3-a]quinolizin-5-ium-2-yl]ethanol

C19H21N2O+ (293.1653796)

KZ6M6HT7DB

Phe-Gly-Ala

Ser-Ser-Thr

Brasilamide M

N(2)-[(R)-2-amino-2-phenylacetyl]-N-butyl-L-serinamide

N(2)-[(R)-2-amino-2-(4-hydroxyphenyl)acetyl]-N-butyl-L-alaninamide

methyl 4,6-dideoxy-4-[(2S)-2,4-dihydroxybutanamido]-2-O-methyl-alpha-D-mannopyranoside

4-[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypyrrolidine-2-carboxylic acid

(2S)-2-azaniumyl-5-{[(1S)-1-carboxylato-2-phenylethyl]amino}-5-oxopentanoate

C14H17N2O5- (293.1137412)

6-Methyl-3-[2-(4-methylphenyl)-2-oxoethyl]-1,4-benzoxazin-2-one

C15H16FNO4 (293.10633079999997)

trimethyl-[(1R,9S)-1-methyl-16-azatetracyclo[7.6.1.02,7.010,15]hexadeca-2,4,6,10(15),11,13-hexaen-13-yl]silane

C19H23NSi (293.1599678)

trimethyl-[(1S,9R)-1-methyl-16-azatetracyclo[7.6.1.02,7.010,15]hexadeca-2,4,6,10(15),11,13-hexaen-13-yl]silane

C19H23NSi (293.1599678)

4-Acetyl-5-(4-fluorophenyl)-1-(2-methoxyethyl)pyrrolidine-2,3-dione

2-amino-5-(aminomethyl)-7-[4-hydroxy-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-3H-pyrrolo[2,3-d]pyrimidin-4-one

N-Piperoylaniline

N-(3,3-Diphenylpropionyl)pyrrolidin-2-one

N-Methyl-N-bis(trimethylsilyl)methylbenzamide

C15H27NOSi2 (293.1631092)

2,2-Dimethyl-3-[[[(1-phenylethyl)amino]carbonyl]oxy]propionic acid ethyl ester

N-Acetyl-Muramic Acid

Koenimbine

GYKI 52466

4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine

Phenylalanyllysine

Glutaminylphenylalanine

N-Acetyl-3-hydroxyprocainamide

Phenylalanyl-Gamma-glutamate

N-(1-Deoxy-1-fructosyl)leucine

N-(1-Deoxy-1-fructosyl)isoleucine

Phenanthro(3,4-d)-1,3-dioxole-5-ethanamine, N,N-dimethyl-

Phenylalanyl-Lysine

2-[3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoic acid

glutaminyl-phenylalanine

gamma-Glu-Phe(1-)

C14H17N2O5 (293.1137412)

A peptide anion obtained by deprotonation of both carboxy groups and protonation of the glutamyl amino group of gamma-Glu-Phe. Major species at pH 7.3.

(8R)-7-prop-2-enyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-13,14-diol

Acetamidonitrazepam

C13H27NO4S (293.16607020000004)

NA-Taurine 11:0

NA-Tyr 7:0

C12H19N7O2 (293.16001539999996)

Cyclo(Arg-His)

Ala-Phe-Gly

Gly-Ala-Phe

(+)-N-Allylnormetazocine (hydrochloride)

C17H24ClNO (293.1546324)

(+)-N-Allylnormetazocine ((+)-SKF 10047) hydrochloride is a benzomorphan opioid with psychotomi metic effects. (+)-N-Allylnormetazocine hydrochloride is an opioid receptor antagonist with Ki values of 300 nM and 27 μM for σ1 and σ2 opioid receptors, respectively. (+)-N-Allylnormetazocine hydrochloride can be used for the research of neurological disease[1][2].

CP94253 (hydrochloride)

CP94253 hydrochloride is a potent and selective agonist of 5-HT1B receptor (Ki= 2 nM in a radioligand binding assay).Ki values for 5-HT1A, 5-HT1D, 5-HT1C and 5-HT2 receptors are 89, 49, 860, and 1600 nM respectively[1]. CP94253 hydrochloride is centrally active upon systemic administration in vivo[2].

9-hydroxy-2,2-dimethyl-11h-pyrano[2,3-a]carbazole-8-carbaldehyde

11-hydroxy-2,2-dimethyl-5h-1-oxa-5-azatetraphen-10-one

3,4,6-trimethyl-9-phenyl-7-oxa-11-azatricyclo[6.4.0.0²,⁶]dodeca-1(12),4,8,10-tetraen-12-ol

(12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene-11-carbaldehyde

9-methoxy-3,3,10-trimethyl-7h-pyrano[2,3-c]carbazole

3,3-dihydroxy-2-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

3-hydroxy-2-oxodendrobine

{"Ingredient_id": "HBIN008646","Ingredient_name": "3-hydroxy-2-oxodendrobine","Alias": "NA","Ingredient_formula": "C16H23NO4","Ingredient_Smile": "NA","Ingredient_weight": "293.36","OB_score": "NA","CAS_id": "99616-00-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8095","PubChem_id": "NA","DrugBank_id": "NA"}

9-methoxy-3,3,8-trimethyl-11h-pyrano[3,2-a]carbazole

(1r,4r,5s)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-4-propyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

(2e)-5-[(1r,2s,5r,6s,7s)-5-hydroxy-6-methyl-3-oxo-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl]-2-methyl-4-oxopent-2-enimidic acid